Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Recipharm’s Erdosteine to be Tested for COVID-19 Treatment | Contract Pharma

What are you searching for?

Sign in
Breaking News

Recipharm’s Erdosteine to be Tested for COVID-19 Treatment

Trial in Italy evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2.

By: Contract Pharma

Contract Pharma Staff

Recipharm’s Erdosteine molecule will be tested in a clinical study as an add-on treatment for COVID-19 patients.

The clinical study, which began on April 7th, is being conducted in clinical centers involved in COVID-19 treatment in Milan and Bergamo. Both Milan and Bergamo are based in Lombardy, the Italian region most affected by the virus.

The study involves around 100 patients affected by COVID-19 and discharged from hospitals. It is evaluating if Erdosteine improves respiratory symptoms and reduces the time to reach a negative test result for SARS-CoV-2. First results from the study are expected in two months.

The theory is that the multiple mechanisms of action of Erdosteine (antioxidant, mucoactive, anti-inflammatory and antibiotic enhancer) may improve respiratory function and could thus potentially benefit patients affected by COVID-19.

Erdosteine was discovered and developed in Italy at Recipharm’s facility in Paderno Dugnano and is indicated for the treatment of acute and chronic respiratory diseases including Chronic Obstructive Pulmonary Disease (COPD).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics